TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Tianjin Institute Of Pharmaceutical Research
US Patent
Tianjin Institute Of Pharmaceutical Research
US Patent
Affinity DataIC50: 0.670nMAssay Description:IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t...More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Tianjin Institute Of Pharmaceutical Research
US Patent
Tianjin Institute Of Pharmaceutical Research
US Patent
Affinity DataIC50: 3.30nMAssay Description:IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t...More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Tianjin Institute Of Pharmaceutical Research
US Patent
Tianjin Institute Of Pharmaceutical Research
US Patent
Affinity DataIC50: 7.80nMAssay Description:IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t...More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Tianjin Institute Of Pharmaceutical Research
US Patent
Tianjin Institute Of Pharmaceutical Research
US Patent
Affinity DataIC50: 86nMAssay Description:IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t...More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Tianjin Institute Of Pharmaceutical Research
US Patent
Tianjin Institute Of Pharmaceutical Research
US Patent
Affinity DataIC50: 187nMAssay Description:IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t...More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Tianjin Institute Of Pharmaceutical Research
US Patent
Tianjin Institute Of Pharmaceutical Research
US Patent
Affinity DataIC50: 251nMAssay Description:IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t...More data for this Ligand-Target Pair